From July 1, 2022 to September 30, 2022, the company has repurchased 169,090 shares, representing 0.82% for KRW 2,231.28 million. With this, the company has completed the repurchase of 380,360 shares, representing 1.86% for KRW 4,984.4 million under the buyback announced on May 17, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22,100 KRW | -0.67% | -3.07% | +7.28% |
2023 | Genomictree Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2022 | Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.28% | 377M | |
+28.28% | 42.68B | |
-2.94% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.37% | 24.94B | |
-20.82% | 18.96B | |
+28.72% | 12.3B | |
-2.37% | 11.95B | |
-1.19% | 11.55B |
- Stock Market
- Equities
- A228760 Stock
- News Genomictree Inc.
- Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022.